# Pharmacology

## Cytochrome P-450 (CYP450) Interactions

### Inducers [CSGAR-PP]

- Carbamazepine
- St. John wort
- Griseofulvin
- Alcohol :: chronic
- Rifampin
- Phenytoin
- Phenobarbital

### Substrates [ATWO]

- Anticonvulsants
- Theophylline
- Warfarin
- OCP

### Inhibitors [CIGAR-MASK-QQ]

- Cimetidine
- Isoniazid
- Grapefruit
- Alcohol :: acute
- Ritonavir
- Macrolide
- Amiodarone
- Sulfonamide
- Ketoconazole
- Quinolone
- Quinidine

## Sulfa Drugs [P-FACTSSS]

- Probenecid
- Furosemide
- Acetazolamide
- Celecoxib
- Thiazide
- Sulfonamide
- Sulfasalazine
- Sulfonylurea

## Mechanisms of Action of Medications Targeting Ion Channels

|Mechanism|Medication|Indications|
|-|-|-|
|Na channel activators|Batrachotoxin & Ciguatoxin|-|
|Na channel blockers|Class 1 antiarrhythmics|Arrhythmia|
||Caines|Anesthesia|
||Amiloride & Triamterene|Diuretics :: K-sparing diuretics|
||Carbamazepine|Seizure & Bipolar|
||Phenytoin|Seizure|
||Calcium|-|
||Saxitoxin & Tetrodotoxin|-|
|K channel activators|Diazoxide|Vasodilation & Insulinoma|
||Minoxidil|Vasodilation & Alopecia|
|K channel blockers|Class 3 antiarrhythmics|Arrhythmia|
||Sulfonylurea|DM type 2|
||Aminopyridine|-|
|Ca channel activators|-|-|
|Ca channel blockers|Class 4 antiarrhythmics|Arrhythmia|
||Amlodipine & Nifedipine|Vasodilation|
||Ethosuximide|Seizure :: absence|
||Gabapentin|Seizure & Neuropathic pain|
|Na-K pump blockers|Digoxin & Digitalis|Arrhythmia & Inotrope|
||Ouabain|-|
|H-K pump blockers|Proton pump inhibitors (PPI): -Prazoles|PUD|
|Na-Cl sympoter blockers|Thiazide|Diuretics|
|Na-K-2Cl sympoter blockers|Loop diuretics :: Furosemide|Diuretics|
||Loop diuretics :: Bumetanide|Diuretics|
||Loop diuretics :: Torsemide|Diuretics|
|Na-I sympoter blockers|Thiocyanate|Hyperthyroidism|
||Perchlorate|Hyperthyroidism|
||Iodine|Hyperthyroidism|

## Mechanisms of Action of Medications Targeting Cholinergic Neurons

|Mechanism|Medication|Indications|
|-|-|-|
|Choline uptake inhibitors|Hemicholinium|-|
|Vesicular transporter inhibitors|Vesamicol|-|
|ACh release inhibitors|Botulinum toxin|Muscle relaxant|
|ACh release inducers|-|-|

## Mechanisms of Action of Medications Targeting Adrenergic Neurons

|Mechanism|Medication|Indications|
|-|-|-|
|Tyrosine uptake inhibitors|-|-|
|Vesicular transporter inhibitors|Reserpine|Huntington|
|NE release inhibitors|Bretylium|Arrhythmia|
||Guanethidine|HTN|
|NE release inducers|Tyramine|-|
||Ephedrine|Decongestant|
||Amphetamine|ADHD & Narcolepsy|
||Modafinil|ADHD & Narcolepsy|

## Mechanisms of Action of Medications Targeting Neurotransmitter Release

|Mechanism|Medication|Indications|
|-|-|-|
|ACh release inhibitors|Botulinum toxin|Muscle relaxant|
|ACh release inducers|-|-|
|NE release inhibitors|Bretylium|Arrhythmia|
||Guanethidine|HTN|
|NE release inducers|Tyramine|-|
||Ephedrine|Decongestant|
||Amphetamine|ADHD & Narcolepsy|
||Modafinil|ADHD & Narcolepsy|
|GABA & Glycine release inhibitors|Tetanus toxin|-|
|GABA & Glycine release inducers|-|-|

## Mechanisms of Action of Medications Targeting Neurotransmitter Breakdown

|Mechanism|Medication|Indications|
|-|-|-|
|ACh esterase inhibitors|Edrophonium|Myasthenia diagnosis|
||Pyridostigmine|Myasthenia|
||Neostigmine|Muscle relaxant reversal|
||Physostigmine|Atropine antidote|
||Rivastigmine|Alzheimer|
||Galantamine|Alzheimer|
||Donepezil|Alzheimer|
||Organophosphate & Sarin|Glaucoma|
|MAO inhibitors|Tranylcypromine|Depression|
||Phenelzine|Depression|
||Isocarboxazid|Depression|
||Selegiline|Depression & Parkinson|

## Mechanisms of Action of Medications Targeting Neurotransmitter Reuptake

|Mechanism|Medication|Indications|
|-|-|-|
|NE reuptake inhibitors|Cocaine|Anesthesia|
||Atomoxetine|ADHD|
||Amphetamine|ADHD & Narcolepsy|
||Methylphenidate|ADHD & Narcolepsy|
||TCA & SNRI & NDRI|Depression|
|5-HT reuptake inhibitors|TCA & SNRI & SSRI|Depression|

## Mechanisms of Action of Cholinergic Agonists

|Mechanism|Medication|Indications|
|-|-|-|
|M agonists|Bethanechol|Prokinetics & Urinary retention|
||Carbachol|Glaucoma|
||Methacholine|Asthma diagnosis|
||Pilocarpine|Glaucoma & Xerostomia|
|N agonists|Succinylcholine|Muscle relaxant|

## Mechanisms of Action of Cholinergic Antagonists

|Mechanism|Medication|Indications|
|-|-|-|
|M antagonists|Atropine & Tropicamide|Mydriatics & Cycloplegia|
||Benztropine|Parkinson|
||Ipratropium & Tiotropium|Asthma|
||Scopolamine|Emesis :: motion sickness|
||Oxybutynin & Tolterodine|Urinary incontinence|
||Glycopyrrolate|Anesthesia|
||Antipsychotics|-|
||Antidepressants :: TCA|-|
||1° Antihistamines|-|
|N<sub>N</sub> (Ganglionic) blockers|Hexamethonium|-|
||Mecamylamine|-|
|N<sub>M</sub> (Neuromuscular) blockers|Atracurium|Muscle relaxant|
||Rocuronium|Muscle relaxant|

## Mechanisms of Action of Adrenergic Agonists

|Mechanism|Medication|Indications|
|-|-|-|
|α<sub>1</sub> agonists|Norepinephrine: α<sub>1</sub> > β<sub>1</sub>|Hypotension|
||Phenylephrine|Hypotension & Decongestant|
||Midodrine|Hypotension|
|α<sub>2</sub> agonists|Clonidine|HTN & Opioid withdrawal|
||Brimonidine|Glaucoma|
||Methyldopa|HTN|
|β<sub>1</sub> agonists|Dopamine: D > β<sub>1</sub> > α<sub>1</sub>|Inotrope|
||Dobutamine: β<sub>1</sub> > β<sub>2</sub>|Inotrope|
|β<sub>2</sub> agonists|Albuterol|Asthma :: acute|
||Salmeterol & Formoterol|Asthma :: chronic|
||Terbutaline & Ritodrine|Tocolysis|
|β agonists|Epinephrine: β > α<sub>1</sub>|Hypotension & Asthma & Shock|
||Isoproterenol: β|-|

## Mechanisms of Action of Adrenergic Antagonists

|Mechanism|Medication|Indications|
|-|-|-|
|α<sub>1</sub> antagonists|Tamsulosin|BPH|
||Terazosin|BPH & HTN & PCC|
||Doxazosin|BPH & HTN & PCC|
||Prazosin|BPH & HTN & PCC & PTSD|
|α<sub>2</sub> antagonists|Mirtazapine|Depression|
|α antagonists|Phentolamine|PCC|
||Phenoxybenzamine|PCC|
||Antipsychotics|-|
||Antidepressants :: TCA|-|
||1° Antihistamines|-|
|β<sub>1</sub> antagonists|Acebutolol|Partial agonists|
||Atenolol|Arrhythmia|
||Bisoprolol|HF|
||Esmolol|Arrhythmia & Surgery|
||Metoprolol|Arrhythmia & HF|
|β antagonists|Nadolol|-|
||Pindolol|Partial agonists|
||Propranolol|Arrhythmia|
||Sotalol|Arrhythmia|
||Timolol|Arrhythmia & Glaucoma|
|αβ antagonists|Carvedilol|Arrhythmia & HF|
||Labetalol|Hypertension|

## Cholinergic & Adrenergic Effects [DUMBBEELSS]

|Cholingeric|Adrenergic|
|-|-|
|Diarrhea|Constipation|
|Urinary incontinence|Urinary retention|
|Miosis|Mydriasis & Cycloplegia|
|Bronchoconstriction|Bronchodilation|
|Bradycardia|Tachycardia|
|Emesis|-|
|Excitation|-|
|Lacrimation|Xerophthalmia|
|Salivation|Xerostomia|
|Sweating|Sweating|

## Mechanisms of Action of Medications Targeting Dopamine Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|D<sub>2</sub> agonists|Bromocriptine|Prolactinoma & Parkinson|
||Cabergoline|Prolactinoma|
||Pramipexole|Parkinson|
||Ropinirole|Parkinson|
|D<sub>2</sub> antagonists|Metoclopramide|Emesis & Prokinetics|
||Prochlorperazine|Emesis & Prokinetics|
||Domperidone|Emesis & Prokinetics|
||Droperidol|Emesis & Prokinetics|
||Antipsychotics|Psychosis|

## Mechanisms of Action of Medications Targeting Serotonin Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|5-HT<sub>1</sub> agonists|Buspirone|Anxiety|
||Triptans|Migraine|
|5-HT<sub>2</sub> agonists|Ergotamine|Migraine|
|5-HT<sub>4</sub> agonists|Cisapride|Prokinetics|
|5-HT modulators|Trazodone|Depression & Insomnia|
|5-HT<sub>2</sub> antagonists|2° Antipsychotics|Psychosis & Bipolar|
||Cyproheptadine|Carcinoid & Serotonin syndrome|
|5-HT<sub>3</sub> antagonists|Ondansetron|Emesis|

## Mechanisms of Action of Medications Targeting Histamine Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|H<sub>1</sub> antagonists|1° Antihistamine :: Chlorpheniramine|Allergy & Emesis :: motion sickness|
||1° Antihistamine :: Diphenhydramine|Allergy & Emesis :: motion sickness|
||1° Antihistamine :: Meclizine|Allergy & Emesis :: motion sickness|
||1° Antihistamine :: Promethazine|Allergy & Emesis :: motion sickness|
||2° Antihistamine :: Cetirizine|Allergy|
||2° Antihistamine :: Fexofenadine|Allergy|
||2° Antihistamine :: Loratadine|Allergy|
||Antipsychotics|-|
||Antidepressants :: TCA|-|
|H<sub>2</sub> antagonists|Cimetidine|PUD|
||Ranitidine|PUD|
||Famotidine|PUD|
||Nizatidine|PUD|

## Mechanisms of Action of Medications Targeting Glutamate Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|NMDA agonists|-|-|
|NMDA antagonists|Ketamine|Anesthesia|
||Memantine|Alzheimer|
||Amantadine|Parkinson|
||Riluzole|Amyotrophic lateral sclerosis (ALS)|
||Dextromethorphan|Coughing|

## Mechanisms of Action of Medications Targeting GABA Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|GABA-A agonists|Barbiturate|Anesthesia & Seizure|
||Benzodiazepine|Anesthesia & Seizure|
||Propofol|Anesthesia|
||Etomidate|Anesthesia|
||Alcohol|-|
|GABA-B agonists|Baclofen|Spasm|
|GABA-A antagonists|Flumazenil|Benzodiazepine antidote|
|GABA-B antagonists|-|-|

## Mechanisms of Action of Medications Targeting Opioid Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|μ-opioid agonists|Codeine|Analgesia|
||Tramadol|Analgesia|
||Meperidine|Analgesia|
||Morphine|Analgesia & Venodilators|
||Fentanyl|Analgesia|
||Loperamide|Diarrhea|
||Diphenoxylate|Diarrhea|
||Dextromethorphan|Coughing|
||Methadone|Opioid cessation|
||Buprenorphine|Opioid cessation|
||Heroin|-|
|μ-opioid antagonists|Naloxone|Opioid antidote|
||Naltrexone|Alcohol cessation|

## Mechanisms of Action of Medications Targeting Vasopressin Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|V<sub>2</sub> agonists|Desmopressin|DI|
|V<sub>2</sub> antagonists|Demeclocycline|SIADH|
||Vaptans|SIADH|
||Lithium|SIADH & Bipolar|

## Mechanisms of Action of Medications Targeting Autacoid Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|PGE1 agonists|Misoprostol|Abortion & PUD|
||Alprostadil|Impotence & PDA maintenance|
|PGF2 agonists|Latanoprost|Glaucoma|
|PGI2 agonists|Epoprostenol|Pulmonary HTN|
|TXA2 antagonists|-|-|
|LTD<sub>4</sub> antagonists|Montelukast|Asthma|
||Zafirlukast|Asthma|

## Mechanisms of Action of Medications Targeting Growth Hormone

|Mechanism|Medication|Indications|
|-|-|-|
|Somatostatin agonists|Octreotide|Acromegaly & Esophageal varices & Carcinoid & VIPoma & Gastrinoma & Glucagonoma|
|GH antagonists|Pegvisomant|Acromegaly|
|IGF-1 agonists|Mecasermin|Dwarfism|

## Mechanisms of Action of Medications Targeting Thyroid Hormone

|Mechanism|Medication|Indications|
|-|-|-|
|Thyroid peroxidase inhibitors|Propylthiouracil (PTU)|Hyperthyroidism|
||Methimazole|Hyperthyroidism|
||Iodine & Lugol solution|Hyperthyroidism|
|Deiodinase inhibitors|Propylthiouracil (PTU)|Hyperthyroidism|
||Steroids & Propranolol|Hyperthyroidism|
|TH agonists|Levothyroxine|Hypothyroidism|
||Triiodothyronine|Hypothyroidism|

## Mechanisms of Action of Medications Targeting Sex Hormones

|Mechanism|Medication|Indications|
|-|-|-|
|GnRH agonists|Leuprolide :: pulsatile|Infertility|
|GnRH antagonists|Leuprolide :: continuous|Prostate cancer|
|Estrogen agonists|Diethylstilbestrol (DES)|HRT & OCP|
||Mestranol|HRT & OCP|
|Estrogen modulators|Clomifene|PCOS & Ovulation|
||Tamoxifen|Breast cancer|
||Raloxifene|Breast cancer & Osteoporosis|
|Progesterone agonists|Progestin|HRT & OCP|
||Medroxyprogesterone|HRT & OCP|
||Norethindrone|HRT & OCP|
||Desogestrel|HRT & OCP|
|Progesterone antagonists|Mifepristone (RU486)|Abortion|
|Aromatase inhibitors|Anastrozole|Breast cancer|
||Letrozole|Breast cancer|
||Exemestane|Breast cancer|
|Androgen agonists|Danazol|Hypogonadism & Endometriosis|
||Methyltestosterone|Hypogonadism|
|Androgen antagonists|Flutamide|Prostate cancer|
||Bicalutamide|Prostate cancer|
||Ketoconazole|PCOS|
||Spironolactone|PCOS|
|5α-Reductase inhibitors|Finasteride|BPH & Alopecia|
||Spironolactone|Hirsutism|

## Mechanisms of Action of Medications Targeting Enzymes

|Mechanism|Medication|Indications|
|-|-|-|
|PDE inhibitors|Inamrinone & Milrinone|Inotrope|
||Methylxanthine: Theophylline & Caffeine|Asthma|
||Sildenafil & Vardenafil|Impotence & Pulmonary HTN|
||Dipyridamole & Cilostazol|Antiplatelet & Vasodilation|
|PLA inhibitors|Steroids|Inflammation|
|COX inhibitors|Acetaminophen|Inflammation|
|COX inhibitors :: NSAIDs|Aspirin|Inflammation|
||Ibuprofen|Inflammation|
||Naproxen|Inflammation|
||Ketorolac|Inflammation|
||Diclofenac|Inflammation|
||Meloxicam|Inflammation|
||Indomethacin|Inflammation & PDA closure|
|COX-2 inhibitors|Celecoxib|Arthritis|
|LOX inhibitors|Zileuton|Asthma|
|ADH inhibitors|Ethanol|Methanol antidote|
||Fomepizole|Methanol antidote|
|ALDH inhibitors|Disulfiram|Alcohol cessation|

## Mechanisms of Action of Antimicrobial and Anticancer Medications

|Mechanism|Targets|Species|
|-|-|-|
|Cell wall inhibitors|Peptidoglycan|Bacterium|
||Mycolate|Mycobacterium|
||Arabinogalactan (AG)|Mycobacterium|
||β-glucan|Fungus|
|Cell membrane inhibitors|Ergosterol|Fungus|
||Cholesterol|Human|
|Metabolite inhibitors|Purine & Pyrimidine & Folate|-|
|Microtubule inhibitors|Microtubule|-|
|DNA inhibitors|DNA|-|
|RNA inhibitors|RNA|-|
|Protein inhibitors|Ribosome|-|

### Cell Wall Inhibitors

|Medication|Mechanism|Targets|Species|
|-|-|-|-|
|Penicillin|↓ Peptidoglycan crosslinking|Penicillin binding protein|Bacterium|
|Cephalosporin|↓ Peptidoglycan crosslinking|Penicillin binding protein|Bacterium|
|Monobactam|↓ Peptidoglycan crosslinking|Penicillin binding protein|Bacterium|
|Carbapenem|↓ Peptidoglycan crosslinking|Penicillin binding protein|Bacterium|
|Glycopeptide|↓ Peptidoglycan synthesis|Peptidoglycan|Bacterium|
|Isoniazid|↓ Mycolate synthesis|-|Mycobacterium|
|Ethambutol|↓ Arabinogalactan synthesis|Arabinosyl transferase|Mycobacterium|
|Echinocandin|↓ β-glucan synthesis|-|Fungus|

### Cell Membrane Inhibitors

|Medication|Mechanism|Targets|Species|
|-|-|-|-|
|Daptomycin|↑ Cell membrane damage|-|Bacterium|
|Polymyxin|↑ Cell membrane damage|-|Bacterium|
|Amphotericin B|↑ Cell membrane damage|Ergosterol|Fungus|
|Nystatin|↑ Cell membrane damage|Ergosterol|Fungus|
|Terbinafine|↓ Ergosterol synthesis|Squalene epoxidase|Fungus|
|Azoles|↓ Ergosterol synthesis|Demethylase|Fungus|

### Metabolite Inhibitors

|Medication|Mechanism|Targets|Species|
|-|-|-|-|
|Ribavirin|↓ Purine synthesis|IMP dehydrogenase|Virus|
|Mycophenolate|↓ Purine synthesis|IMP dehydrogenase|Human|
|Azathioprine|↓ Purine synthesis|-|Human|
|Mercaptopurine (6-MP)|↓ Purine synthesis|-|Human|
|Thioguanine (6-TG)|↓ Purine synthesis|-|Human|
|Leflunomide|↓ Pyrimidine synthesis|Dihydroorotate dehydrogenase|Human|
|Flucytosine|↓ Pyrimidine synthesis|Thymidylate synthase|Fungus|
|Fluorouracil (5-FU)|↓ Pyrimidine synthesis|Thymidylate synthase|Human|
|Hydroxyurea|↓ Purine & Pyrimidine synthesis|Ribonucleotide reductase|Human|
|Sulfonamide|↓ Folate synthesis|Dihydropteroate synthase|Bacterium|
|Trimethoprim|↓ Folate synthesis|Dihydrofolate reductase|Bacterium|
|Pyrimethamine|↓ Folate synthesis|Dihydrofolate reductase|Protozoa|
|Methotrexate|↓ Folate synthesis|Dihydrofolate reductase|Human|

### Microtubule Inhibitors

|Medication|Mechanism|Targets|Species|
|-|-|-|-|
|Benzimidazole|↓ Microtubule assembly|Microtubule|Parasite|
|Griseofulvin|↓ Microtubule assembly|Microtubule|Fungus|
|Colchicine|↓ Microtubule assembly|Microtubule|Human|
|Vincas|↓ Microtubule assembly|Microtubule|Human|
|Taxanes|↓ Microtubule disassembly|Microtubule|Human|

### DNA Inhibitors

|Medication|Mechanism|Targets|Species|
|-|-|-|-|
|Fluoroquinolone|↓ DNA synthesis|Topoisomerase|Bacterium|
|Tecans|↓ DNA synthesis|Topoisomerase 1|Human|
|Etoposide|↓ DNA synthesis|Topoisomerase 2|Human|
|Teniposide|↓ DNA synthesis|Topoisomerase 2|Human|
|Cytarabine|↓ DNA synthesis|DNA polymerase|Human|
|Acyclovir|↓ DNA synthesis|DNA polymerase|Virus|
|Famciclovir|↓ DNA synthesis|DNA polymerase|Virus|
|Ganciclovir|↓ DNA synthesis|DNA polymerase|Virus|
|Cidofovir|↓ DNA synthesis|DNA polymerase|Virus|
|Foscarnet|↓ DNA synthesis|DNA polymerase|Virus|
|NRTI & NNRTI|↓ DNA synthesis|Reverse transcriptase|Virus|
|Metronidazole|↑ DNA intercalation|DNA|Bacterium|
|Streptomycin|↑ DNA intercalation|DNA|Mycobacterium|
|Bleomycin|↑ DNA intercalation|DNA|Human|
|Dactinomycin|↑ DNA intercalation|DNA|Human|
|Doxorubicin|↑ DNA intercalation|DNA|Human|
|Daunorubicin|↑ DNA intercalation|DNA|Human|
|Nitrosourea|↑ DNA crosslinking|DNA|Human|
|Busulfan|↑ DNA crosslinking|DNA|Human|
|Cyclophosphamide|↑ DNA crosslinking|DNA|Human|
|Platinums|↑ DNA crosslinking|DNA|Human|

### RNA Inhibitors

|Medication|Mechanism|Targets|Species|
|-|-|-|-|
|Rifampin|↓ RNA synthesis|RNA polymerase|Mycobacterium|
|Dactinomycin|↓ RNA synthesis|RNA polymerase|Human|
|α-Amanitin|↓ RNA synthesis|RNA polymerase|Human|

### Protein Inhibitors

|Medication|Mechanism|Targets|Species|
|-|-|-|-|
|IFN-α|↓ Protein synthesis|-|Virus|
|Aminoglycoside|↓ Protein synthesis|30S ribosome :: initiation complex|Bacterium|
|Linezolid|↓ Protein synthesis|50S ribosome :: initiation complex|Bacterium|
|Tetracycline|↓ Protein synthesis|30S ribosome :: tRNA binding|Bacterium|
|Chloramphenicol|↓ Protein synthesis|50S ribosome :: peptidyl transferase|Bacterium|
|Macrolide|↓ Protein synthesis|50S ribosome :: mRNA translocation|Bacterium|
|Clindamycin|↓ Protein synthesis|50S ribosome :: mRNA translocation|Bacterium|
|Diphtheria toxin|↓ Protein synthesis|Elongation factor (EF-2)|Human|
|Exotoxin A|↓ Protein synthesis|Elongation factor (EF-2)|Human|
|Shiga toxin|↓ Protein synthesis|60S ribosome|Human|
|Shiga-like toxin|↓ Protein synthesis|60S ribosome|Human|

## Mechanisms of Action of Monoclonal Antibodies

|Mechanism|Medication|Indications|
|-|-|-|
|Gp2b/3a inhibitors|Abxicimab|Antiplatelet|
|RANKL inhibitors|Denosumab|Osteoporosis|
|IgE inhibitors|Omalizumab|Asthma|
|IL-2R inhibitors|Basiliximab|Immunosuppression|
||Daclizumab|Immunosuppression|
|TNF-α inhibitors|Infliximab|Immunosuppression|
||Adalimumab|Immunosuppression|
|CD20 inhibitors|Rituximab|Immunosuppression & Non-Hodgkin lymphoma|
|EGFR inhibitors|Cetuximab|Colon & Lung cancer|
|HER2 inhibitors|Trastuzumab|Breast cancer|
|VEGF inhibitors|Bevacizumab|Solid tumors|
||Ranibizumab|Diabetic retinopathy|
|CAM inhibitors|Natalizumab|Multiple sclerosis|
|F protein inhibitors|Palivizumab|RSV|

## Mechanisms of Action of Tyrosine Kinase Inhibitors

|Mechanism|Medication|Indications|
|-|-|-|
|BRAF inhibitors|Vemurafenib|Melanoma|
|BCR-ABL inhibitors|Imatinib|CML|
|C-KIT inhibitors|Imatinib|Gastrointestinal stromal tumor (GIST)|
|EGFR inhibitors|Gefitinib & Erlotinib|Non-small cell lung cancer|
|VEGFR inhibitors|Sunitinib & Sorafenib|-|

## Target Therapy

![](../Figures/Target%20Therapy.png)

## Medications Causing QT Prolongation [ABCDE]

- Antiarrhythmics :: class 1A & 3
- Antibiotics :: Macrolide & Fluoroquinolone
- Antipsychotics
- Antidepressants :: TCA
- Antiemetics :: Ondansetron

## Medications Causing Agranulocytosis

|Mnemonic|Medication|
|-|-|
|Cannot|Carbamazepine|
|Make|Methimazole|
|Circulating|Clozapine|
|Granulo-|Ganciclovir|
|Cytes|Colchicine|
|Properly|Propylthiouracil|

## Medications Causing Aplastic Anemia

|Mnemonic|Medication|
|-|-|
|Cannot|Carbamazepine|
|Make|Methimazole|
|New|NSAIDs|
|Blood|Benzene|
|Cells|Chloramphenicol|
|Properly|Propylthiouracil|

## Medications Causing Megaloblastic Anemia

- Methotrexate
- Phenytoin
- Sulfa drugs
- Trimethoprim

## Medications Causing Hemolysis in G6PD Deficiency [IS-D-PAIN]

- Isoniazid
- Sulfonamide
- Dapsone
- Primaquine
- Aspirin
- Ibuprofen
- Nitrofurantoin

## Medications Causing Osteoporosis

- Corticosteroid
- Heparin

## Medications Causing Photosensitivity

- Sulfonamide
- Amiodarone
- Tetracycline
- Flucytosine

## Medications Causing SLE-like Syndrome [HIPPIES]

- Hydralazine
- Isoniazid
- Procainamide
- Primaquine
- Isoniazid
- Etanercept
- Sulfa drugs

## Medications Causing Seizures

- Bupropion
- Enflurane
- Imipenem
- Isoniazid

## Medications Causing Parkinson-like Syndrome [RAM]

- Reserpine
- Antipsychotics
- Metoclopramide

## Medications Causing Disulfiram-like Reaction

- Griseofulvin
- Metronidazole
- Procarbazine
- Sulfonylurea

## Medications Causing Nephrotoxicity & Ototoxicity

- Aminoglycoside
- Cisplatin
- Loop diuretics
- Vancomycin

## Medications Causing Gynecomastia

|Mnemonic|Medication|
|-|-|
|Some|Spironolactone|
|Drugs|Digoxin|
|Create|Cimetidine|
|Awesome|Alcohol|
|Knockers|Ketoconazole|

## Medications Causing SIADH

|Mnemonic|Medication|
|-|-|
|Cannot|Carbamazepine|
|Concentrate|Cyclophosphamide|
|Sodium|SSRI|

## Medications Following Zero-order Elimination [APE]

- Aspirin
- Phenytoin
- Ethanol
